Literature DB >> 28400521

An antivascular vaccine to boost self-immunity and strike the tumor.

Serena Marchiò1,2,3, Pranshu Bansal1,4, Renata Pasqualini5,2, Wadih Arap5,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28400521      PMCID： PMC5402401          DOI： 10.1073/pnas.1701452114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  10 in total

1.  Spontaneous regression of pulmonary metastases from renal cell carcinoma after radio frequency ablation of primary tumor: an in situ tumor vaccine?

Authors:  Ricardo F Sánchez-Ortiz; Nizar Tannir; Kamran Ahrar; Christopher G Wood
Journal:  J Urol       Date:  2003-07       Impact factor: 7.450

Review 2.  Cancer despite immunosurveillance: immunoselection and immunosubversion.

Authors:  Laurence Zitvogel; Antoine Tesniere; Guido Kroemer
Journal:  Nat Rev Immunol       Date:  2006-09-15       Impact factor: 53.106

3.  Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity.

Authors:  Madelon Q Wentink; Tilman M Hackeng; Sebastien P Tabruyn; Wouter C Puijk; Klaus Schwamborn; Daniele Altschuh; Rob H Meloen; Teun Schuurman; Arjan W Griffioen; Peter Timmerman
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-17       Impact factor: 11.205

Review 4.  Antiangiogenic therapy in oncology: current status and future directions.

Authors:  Gordon C Jayson; Robert Kerbel; Lee M Ellis; Adrian L Harris
Journal:  Lancet       Date:  2016-02-05       Impact factor: 79.321

5.  Discovery and horizontal follow-up of an autoantibody signature in human prostate cancer.

Authors:  Paul J Mintz; Anna Cecilia Rietz; Marina Cardó-Vila; Michael G Ozawa; Eleonora Dondossola; Kim-Anh Do; Jeri Kim; Patricia Troncoso; Christopher J Logothetis; Richard L Sidman; Renata Pasqualini; Wadih Arap
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-09       Impact factor: 11.205

6.  An HSP90-mimic peptide revealed by fingerprinting the pool of antibodies from ovarian cancer patients.

Authors:  Claudia I Vidal; Paul J Mintz; Karen Lu; Lee M Ellis; Luigi Manenti; Raffaella Giavazzi; David M Gershenson; Russell Broaddus; Jinsong Liu; Wadih Arap; Renata Pasqualini
Journal:  Oncogene       Date:  2004-11-25       Impact factor: 9.867

7.  TGF-β and VEGF cooperatively control the immunotolerant tumor environment and the efficacy of cancer immunotherapies.

Authors:  Tristan Courau; Djamel Nehar-Belaid; Laura Florez; Béatrice Levacher; Thomas Vazquez; Faustine Brimaud; Bertrand Bellier; David Klatzmann
Journal:  JCI Insight       Date:  2016-06-16

Review 8.  Meta-analysis of regression of advanced solid tumors in patients receiving placebo or no anti-cancer therapy in prospective trials.

Authors:  Pooja Ghatalia; Charity J Morgan; Guru Sonpavde
Journal:  Crit Rev Oncol Hematol       Date:  2015-11-09       Impact factor: 6.312

9.  Fingerprinting the circulating repertoire of antibodies from cancer patients.

Authors:  Paul J Mintz; Jeri Kim; Kim-Anh Do; Xuemei Wang; Ralph G Zinner; Massimo Cristofanilli; Marco A Arap; Waun Ki Hong; Patricia Troncoso; Christopher J Logothetis; Renata Pasqualini; Wadih Arap
Journal:  Nat Biotechnol       Date:  2002-12-23       Impact factor: 54.908

10.  Hereditary renal cell carcinoma in the Eker rat: a rodent familial cancer syndrome.

Authors:  J I Everitt; T L Goldsworthy; D C Wolf; C L Walker
Journal:  J Urol       Date:  1992-12       Impact factor: 7.450
  10 in total
  1 in total

1.  Reply to Marchiò et al.: Antitumor immune regulation by angiostatic therapy.

Authors:  Madelon Q Wentink; Elisabeth J M Huijbers; Peter Timmerman; Arjan W Griffioen
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-11       Impact factor: 11.205
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.